These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 18853999)

  • 1. Occult hepatitis B virus infection in Southern African blacks with hepatocellular carcinoma.
    Kew MC; Welschinger R; Viana R
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1426-30. PubMed ID: 18853999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on sequence variations in pre-S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non-B, non-C hepatocellular carcinoma patients in Taiwan.
    Chen CH; Changchien CS; Lee CM; Tung WC; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
    Int J Cancer; 2009 Aug; 125(3):621-9. PubMed ID: 19431214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?
    Vitale F; Tramuto F; Orlando A; Vizzini G; Meli V; Cerame G; Mazzucco W; Virdone R; Palazzo U; Villafrate MR; Tagger A; Romano N
    J Med Virol; 2008 Apr; 80(4):577-82. PubMed ID: 18297707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T1653 mutation in the enhancer II region of the hepatitis B virus genome in southern African Blacks with hepatocellular carcinoma.
    Welschinger R; Kew MC; Viana R; Badri M
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):541-5. PubMed ID: 20173647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa.
    Mphahlele MJ; Lukhwareni A; Burnett RJ; Moropeng LM; Ngobeni JM
    J Clin Virol; 2006 Jan; 35(1):14-20. PubMed ID: 15916918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and Characteristics of Occult Hepatitis B Infection Among Hepatocellular Carcinoma Patients in Japan.
    Muto J; Sugiyama M; Shirabe K; Mukaide M; Kirikae-Muto I; Ikegami T; Yoshizumi T; Yamashita YI; Maehara Y; Mizokami M
    Ann Hepatol; 2018 July - August ,; 17(4):596-603. PubMed ID: 29893701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide sequence of the precore/core gene and X gene of hepatitis B virus DNA in asymptomatic hepatitis B virus carriers who are negative for serum hepatitis B core antibody.
    Terada T; Moriyama M; Uchida T; Arakawa Y
    Intervirology; 2001; 44(4):243-9. PubMed ID: 11509887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
    Martin LA; Stramer SL; Kuhns MC; Schlauder GG
    Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult hepatitis B virus infection in patients with chronic liver disease due to hepatitis C virus and hepatocellular carcinoma in Brazil.
    Branco F; Mattos AA; Coral GP; Vanderborght B; Santos DE; França P; Alexandre C
    Arq Gastroenterol; 2007; 44(1):58-63. PubMed ID: 17639185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus infection and hepatocellular carcinoma: correlation between IgM antibody to hepatitis B core antigen, hepatitis B e antigen, and hepatitis B DNA.
    Sjogren MH; Dusheiko GM; Kew MC; Song E
    Am J Trop Med Hyg; 1988 Dec; 39(6):582-5. PubMed ID: 2849883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus DNA in serum of healthy black African adults positive for hepatitis B surface antibody alone: possible association with recombination between genotypes A and D.
    Owiredu WK; Kramvis A; Kew MC
    J Med Virol; 2001 Aug; 64(4):441-54. PubMed ID: 11468728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
    Motta JS; Mello FC; Lago BV; Perez RM; Gomes SA; Figueiredo FF
    J Gastroenterol Hepatol; 2010 Jan; 25(1):101-6. PubMed ID: 19817965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of genotype D in chronic liver disease patients with occult HBV infection in northern region of India.
    Rizvi M; Azam M; Sultan A; Shukla I; Malik A; Ajmal MR; Khan F; Sami H
    Indian J Pathol Microbiol; 2014; 57(4):537-41. PubMed ID: 25308003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients.
    El-Sherif A; Abou-Shady M; Abou-Zeid H; Elwassief A; Elbahrawy A; Ueda Y; Chiba T; Hosney AM
    J Gastroenterol; 2009; 44(4):359-64. PubMed ID: 19271112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis-B virus infection in black children with hepatocellular carcinoma.
    Kew MC; Hodkinson J; Paterson AC; Song E
    J Med Virol; 1982; 9(3):201-7. PubMed ID: 6284871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa.
    Barth RE; Huijgen Q; Tempelman HA; Mudrikova T; Wensing AM; Hoepelman AI
    J Med Virol; 2011 Jun; 83(6):929-34. PubMed ID: 21503902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.
    Baghbanian M; Halvani M; Roghani HS; Lotfi MH; Yazdi MF; Vahedian-Ardakani HA
    Arq Gastroenterol; 2016; 53(3):175-9. PubMed ID: 27438423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen.
    Kuhns MC; Holzmayer V; Anderson M; McNamara AL; Sauleda S; Mbanya D; Duong PT; Dung NTT; Cloherty GA
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.